image description
image description
Tell A Friend

FinancialNews


  • 22-09-10

    Dubai's NewBridge secures $12m financing

    (MENAFN) Dubai-based NewBridge Pharmaceuticals said that it has completed its $12 million Series B financing, bringing the total amount raised to $16 million, Reuters reported. The Series B financing round was led by Kuwait Life Sciences Company (KLSC), a subsidiary of National Technology Enterprises Company of Kuwait with participation by the previous investor Burrill Life Sciences Capital Fund III, L.P. NewBridge is a specialty pharmaceutical, biologics, medical devices and diagnostics company serving the emerging markets of Africa, Middle East, Turkey, and Caspian regions.

Follow us

RSS
Terms & Conditions  |  Privacy & Security  |  Contact Us  | Sitemap
© 2024 BBK  |  All Rights Reserved